| A diet low in FODMAPs reduces symptoms of irritable bowel syndrome EP Halmos, VA Power, SJ Shepherd, PR Gibson, JG Muir Gastroenterology 146 (1), 67-75. e5, 2014 | 1650 | 2014 |
| No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates JR Biesiekierski, SL Peters, ED Newnham, O Rosella, JG Muir, ... Gastroenterology 145 (2), 320-328. e3, 2013 | 1128 | 2013 |
| Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial JR Biesiekierski, ED Newnham, PM Irving, JS Barrett, M Haines, ... Official journal of the American College of Gastroenterology| ACG 106 (3 …, 2011 | 1099 | 2011 |
| Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis WJ Sandborn, BG Feagan, C Marano, H Zhang, R Strauss, J Johanns, ... Gastroenterology 146 (1), 85-95, 2014 | 1069 | 2014 |
| Evidence‐based dietary management of functional gastrointestinal symptoms: the FODMAP approach PR Gibson, SJ Shepherd Journal of gastroenterology and hepatology 25 (2), 252-258, 2010 | 951 | 2010 |
| Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis WJ Sandborn, BG Feagan, C Marano, H Zhang, R Strauss, J Johanns, ... Gastroenterology 146 (1), 96-109. e1, 2014 | 860 | 2014 |
| Diets that differ in their FODMAP content alter the colonic luminal microenvironment EP Halmos, CT Christophersen, AR Bird, SJ Shepherd, PR Gibson, ... Gut 64 (1), 93-100, 2015 | 843 | 2015 |
| Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome DK Ong, SB Mitchell, JS Barrett, SJ Shepherd, PM Irving, JR Biesiekierski, ... Journal of gastroenterology and hepatology 25 (8), 1366-1373, 2010 | 783 | 2010 |
| Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence SJ Shepherd, FC Parker, JG Muir, PR Gibson Clinical gastroenterology and hepatology 6 (7), 765-771, 2008 | 754 | 2008 |
| Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. A McIntyre, PR Gibson, GP Young Gut 34 (3), 386-391, 1993 | 749 | 1993 |
| Crohn's disease management after intestinal resection: a randomised trial P De Cruz, MA Kamm, AL Hamilton, KJ Ritchie, EO Krejany, A Gorelik, ... The Lancet 385 (9976), 1406-1417, 2015 | 668 | 2015 |
| Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management SJ Shepherd, PR Gibson Journal of the American dietetic association 106 (10), 1631-1639, 2006 | 593 | 2006 |
| Diagnosis and management of iron deficiency anaemia: a clinical update. SRS Pasricha, SC Flecknoe-Brown, KJ Allen, PR Gibson, LP McMahon, ... Medical Journal of Australia 193 (9), 2010 | 537 | 2010 |
| Dietary poorly absorbed, short‐chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon JS Barrett, RB Gearry, JG Muir, PM Irving, R Rose, O Rosella, ML Haines, ... Alimentary pharmacology & therapeutics 31 (8), 874-882, 2010 | 534 | 2010 |
| Personal view: food for thought–western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis PR Gibson, SJ Shepherd Alimentary pharmacology & therapeutics 21 (12), 1399-1409, 2005 | 525 | 2005 |
| Systematic review: exercise‐induced gastrointestinal syndrome—implications for health and intestinal disease RJS Costa, RMJ Snipe, CM Kitic, PR Gibson Alimentary pharmacology & therapeutics 46 (3), 246-265, 2017 | 506 | 2017 |
| Fructan, rather than gluten, induces symptoms in patients with self-reported non-celiac gluten sensitivity GI Skodje, VK Sarna, IH Minelle, KL Rolfsen, JG Muir, PR Gibson, ... Gastroenterology 154 (3), 529-539. e2, 2018 | 504 | 2018 |
| Short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders PA Gill, MC Van Zelm, JG Muir, PR Gibson Alimentary pharmacology & therapeutics 48 (1), 15-34, 2018 | 490 | 2018 |
| Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn’s disease W Selby, P Pavli, B Crotty, T Florin, G Radford-Smith, P Gibson, B Mitchell, ... Gastroenterology 132 (7), 2313-2319, 2007 | 472 | 2007 |
| Quantification of fructans, galacto‐oligosacharides and other short‐chain carbohydrates in processed grains and cereals JR Biesiekierski, O Rosella, R Rose, K Liels, JS Barrett, SJ Shepherd, ... Journal of Human Nutrition and Dietetics 24 (2), 154-176, 2011 | 453 | 2011 |
